Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong · Delayed Price · Currency is HKD 3.030
+0.010 (0.33%)
Jan 21, 2026, 4:08 PM HKT
HKG:1349 Market Cap
HKG:1349 has a market cap or net worth of 7.89 billion as of January 21, 2026. Its market cap has increased by 15.40% in one year.
Market Cap
7.89B
Enterprise Value
6.68B
Revenue
777.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.03
Market Cap Chart
Since August 13, 2002, HKG:1349's market cap has increased from 582.40M to 7.89B, an increase of 1,254.29%. That is a compound annual growth rate of 11.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 7.88B | 5.53% |
| Dec 31, 2025 | 7.47B | 13.14% |
| Dec 31, 2024 | 6.60B | -18.06% |
| Dec 29, 2023 | 8.06B | 3.73% |
| Dec 30, 2022 | 7.77B | -42.18% |
| Dec 31, 2021 | 13.43B | -14.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |